Poly ICLC (Hiltonol®): an immune adjuvant targeting the Toll-like receptor 3 (TLR3) pathway; approved for subsets of patients with squamous cell carcinoma.
Once again, Exwannabe is wrong. A common theme these days. Looking forward to approval of DCVAX which equates to Exwannabe’s disappearance from this board forever. :)
I can buy hiltonol right now from a compounding pharmacy. Go online and check it out. Once its approved those pharmacies wont be advertizing it anymore because they will be sued. Iam hoping that specials program has been including polyicl (hiltonol) in its treatments since 2017... and the results of that real world data are going to be announced a week after the nature article. Mhra approvoal, nature article about polyicl and dcvax 60% alive and then numbers alive from specials program treated at the optimal timing with and without chemo. Seems to me like anyone accepted into the specials program has been sworn to secrecy as no one talks about it. I bet when they are allowed to speak they will be very vocal. So the conversation wont be about comparing 5% survival to 13% survival...It will be about comparing 5% survival to 60% survival in the most lethal cancer. Allow the big investor in first with a purchase of 100 million shares at 3.50 to set a base and get uplisted then let the news flow.